NCT03885375 is a clinical trial in Autoimmune Diseases, sponsored by Peking Union Medical College Hospital.

Who is sponsoring NCT03885375?

NCT03885375 is sponsored by Peking Union Medical College Hospital.

What condition does NCT03885375 study?

NCT03885375 studies Autoimmune Diseases.

Is NCT03885375 still recruiting?

NCT03885375 is currently status unknown. Last updated 21 March 2019.

Last reviewed 2019-03-21 · How we verify

NCT03885375

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Diagnostic and Imaging Indicators of Immunocardiomyopathic Patients

Status unknown Last updated 21 March 2019

What this trial tests

trial in Autoimmune Diseases in 100 participants. Status unknown.

Timeline

1 April 2018

Primary endpoint
1 April 2020

30 April 2020

Quick facts

Lead sponsor	Peking Union Medical College Hospital
Status	Status unknown
Study type	OBSERVATIONAL
Enrollment	100
Start date	1 April 2018
Primary completion	1 April 2020
Estimated completion	30 April 2020
Sites	1 location across China

Conditions studied

Autoimmune Diseases — all drugs for Autoimmune Diseases →

Sponsor

Peking Union Medical College Hospital

Who can join

Adults 18 to 65, any sex, with Autoimmune Diseases. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Cardiac involvements in autoimmune diseases (AD) is common but underestimated and an early detection remains a clinical challenge for lacking of efficient imaging methods. The objective of the study was to investigate LV myocardial abnormalities in AD patients by multimodal cardiac imaging, including speckle-tracking echocardiology (STE), cardiac magnetic resonance imaging (CMRI) and positron emission tomography (PET).

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

Predictive Value of Echocardiographic Strain for Myocardial Fibrosis and Adverse Outcomes in Autoimmune Diseases.
Jia F, Li X, Zhang D, Jiang S, et al · · 2022 · cited 7× · PMID 35265686 · DOI 10.3389/fcvm.2022.836942
Unmasking the Hidden Threat: The Role of Left Ventricular Subendocardial Involvement in Autoimmune Rheumatic Disease.
Wu D, Li X, Guo T, Feng X, et al · · 2025 · PMID 39743740 · DOI 10.1002/clc.70069

Verify or expand the search:

Other recruiting trials for Autoimmune Diseases

Currently open trials in the same condition.

NCT06948110 — Deciphering the Genetic Architecture of Autoimmune Diseases · recruiting
NCT07246096 — Exploratory Clinical Study on the Safety and Efficacy of Anti- CD19/BCMA U CAR-T Cell Injection for the Treatment of Rel · EARLY_PHASE1 · recruiting
NCT07408336 — Clinical Study of AFN50 Injection in the Autoimmune Diseases · EARLY_PHASE1 · recruiting
NCT07283315 — Exploratory Clinical Study of Second-generation CD19/BCMA Chimeric Antigen Receptor NK Cell Injection in Treating Paedia · EARLY_PHASE1 · recruiting
NCT07221890 — A Trial of Academic Detailing to Promote Prescribing of Biosimilars · NA · active not recruiting

Other Peking Union Medical College Hospital trials

Trials by the same sponsor.

NCT07466251 — PCSK9 Inhibitor for Intracranial Atherosclerosis Related Acute Ischemic Stroke · Phase 4 · not yet recruiting
NCT06743321 — Speech-to-speech Voice-cloning Care (SVCC) to Improve ICU-acquired Anxiety for Critically Ill Patients · NA · not yet recruiting
NCT07590336 — 68Ga-NYM207 PET/CT Imaging in Hepatocellular Carcinoma · Phase 1, PHASE2 · not yet recruiting
NCT07515976 — Mapping of Genomic Structural Variations in Major Birth Defects · not yet recruiting
NCT07386756 — Early Precise Identification and Intervention Strategies for Individuals at High Risk of Prediabetes · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03885375 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Peking Union Medical College Hospital
Last refreshed: 21 March 2019

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03885375.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing